Ch. ROUZIOUX, Ph.D.; F. BRUN-VEZINET, M.D.; A.M. COUROUCÉ, Ph.D.; C. GAZENGEL, M.D.; D. VERGOZ, M.D.; J. DESMYTER, M.D.; J. VERMYLEN, M.D.; C. VERMYLEN, M.D.; D. KLATZMANN, M.D.; D. GEROLDI, M.D.; C. BARREAU, Ph.D.; F. BARRÉ-SINOUSSI, Ph.D.; J.C. CHERMANN, Ph.D.; D. CHRISTOL, M.D.; L. MONTAGNIER, M.D.
Grant support: by grants from the Pasteur Institute, French National League Against Cancer, Centre National de la Recherche Scientifique (CRNS, France), and the Belgian Fonds de la Recherche Scientifique Médicale.
▸Requests for reprints should be addressed to Ch. Rouzioux, Ph.D.; Hôpital Claude Bernard, Laboratoire Central de Virologie, 10 avenue de la Porte d'Aubervilliers; 75019 Paris, France.
ROUZIOUX C., BRUN-VEZINET F., COUROUCÉ A., GAZENGEL C., VERGOZ D., DESMYTER J., VERMYLEN J., VERMYLEN C., KLATZMANN D., GEROLDI D., BARREAU C., BARRÉ-SINOUSSI F., CHERMANN J., CHRISTOL D., MONTAGNIER L.; Immunoglobulin G Antibodies to Lymphadenopathy-Associated Virus in Differently Treated French and Belgian Hemophiliacs. Ann Intern Med. 1985;102:476-479. doi: 10.7326/0003-4819-102-4-476
Download citation file:
Published: Ann Intern Med. 1985;102(4):476-479.
Immunoglobulin G antibodies to lymphadenopathy-associated virus have been detected in two groups of French hemophiliacs and in one group of Belgian hemophiliacs, whose mode of treatment differed. Seropositivity was more frequent (58.9%) in patients heavily transfused with blood products of French and foreign origin than in less frequently transfused persons (10.3%). The Belgian group, treated only with local products, showed the lowest frequency of seropositivity (3.4%). In healthy French controls, 1 of 330 had antibody to the virus. The results indicate transmission of lymphadenopathy-associated virus via blood-derived products.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, HIV.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only